ML40787, entitled, A Phase III, prospective, double-blind, randomized, placebo-controlled trial ofTENECTEPLASE IN IMAGING-ELIGIBLE, LATE-WINDOW PATIENTS TO ASSESS THE EFFICACY ANDSAFETY OF TENECTEPLASE (TIMELESS)

Project: Research project

Project Details

Description

ML40787, entitled, A Phase III, prospective, double-blind, randomized, placebo-controlled trial of TENECTEPLASE IN IMAGING-ELIGIBLE, LATE-WINDOW PATIENTS TO ASSESS THE EFFICACY AND SAFETY OF TENECTEPLASE (TIMELESS)
StatusActive
Effective start/end date1/1/1912/31/24

Funding

  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.